Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA grants orphan drug and breakthrough therapy designations to setmelanotide

Jan. 8, 2016

FDA grants fast track designation to Bendavia for primary mitochondrial myopathy

Jan. 8, 2016

Millendo licenses phase II polycystic ovary syndrome candidate from AstraZeneca

Jan. 8, 2016

Sanofi to stop selling MannKind inhaled insulin

Jan. 7, 2016

FDA awards breakthrough therapy designation to VTS-270 for Niemann-Pick type C1 disease

Jan. 7, 2016

Dimension Therapeutics' gene therapy DTX-301 granted FDA orphan drug designation

Jan. 7, 2016

University of Arizona reports melanocorin receptor modulators

Jan. 7, 2016

University of Virginia's artificial pancreas technology to enter pivotal trials in type 1 diabetes

Jan. 5, 2016

NIH grant supports work at MUSC into pancreatitis and diabetes

Jan. 4, 2016

FDA grants orphan drug designation to Pluristem's PLX-PAD for severe preeclampsia

Jan. 4, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...